UPDATE : Monday, February 19, 2018
‘Novo Nordisk Korea has no plan to downsize’ by Nam Doo-hyun 2018-02-13 15:46
Safer, more potent new drugs coming up this year by Nam Doo-hyun 2018-02-12 15:54
‘New combo may become standard soft tissue sarcoma treatment’ by Nam Doo-hyun 2018-02-09 15:50
Immunotherapies claims rose on insurance coverage in 2017 by Nam Doo-hyun 2018-02-07 11:07
Korea’s drug exports increased fastest to China in 2017 by Nam Doo-hyun 2018-02-05 14:36
Will new KRPIA head back US pharma in FTA revision? by Nam Doo-hyun 2018-02-02 14:53
Overheated DHP Korea stocks face short-term trade limit by Nam Doo-hyun 2018-01-31 15:34
Contrast medium market shrank last year by Nam Doo-hyun 2018-01-24 15:14
Antihypertensive, antiarteriosclerotic drugs surged last year by Nam Doo-hyun 2018-01-22 11:35
Which certificates do you need for 4th industrial revolution? by Nam Doo-hyun 2018-01-18 12:18
Shares of ‘Celltrion trio’ plummet on profit-taking by Nam Doo-hyun 2018-01-18 11:10
‘Risk-sharing agreements improved access to expensive drugs’ by Nam Doo-hyun 2018-01-17 16:15
Korea’s pharmaceutical exports up 20% in 2017 by Nam Doo-hyun 2018-01-16 11:21
Shares of eye drops/masks makers rise on fine dust measure by Nam Doo-hyun 2018-01-15 15:48
'Postmenopausal use of aromatase inhibitor ups fracture risk’ by Nam Doo-hyun 2018-01-15 14:42
Gaucher disease drug effective for retention, early treatment, Sanofi says by Nam Doo-hyun 2018-01-15 10:27
Luxturna to open gene therapies market: analyst by Nam Doo-hyun 2018-01-10 15:48
Test for fetal sex chromosome defects wins patent by Nam Doo-hyun 2018-01-10 14:39
Antibodies drug suggested against N. Korean anthrax threat by Nam Doo-hyun 2018-01-05 12:03
Venture capital investment in biomedical sector drops 20% in 2017 by Nam Doo-hyun 2018-01-04 09:30
Back to Top